HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased factor XII activity is associated with recurrent IVF-ET failure.

AbstractPROBLEM:
A decrease in factor XII (FXII) activity has been observed in women with unexplained recurrent miscarriages. Because of the many similarities between recurrent in vitro fertilization-embryo transfer (IVF-ET) failure and early pregnancy loss patients, we investigated whether women with recurrent IVF-ET failure had low FXII activity.
METHOD OF STUDY:
Blood from 110 patients with three or more IVF-ET failures was tested for FXII activity, autoantibodies and other coagulation parameters. These patients were compared with 191 recurrent miscarriage patients, 87 controls. FXII activity was measured by an activated partial thromboplastin time (APTT) assay.
RESULTS:
Factor XII activity of the IVF-ET failure group (median 79.5, range 37-150) was significantly lower than that of control group (median 109, range 35-225, P < 0.001 by Mann-Whitney test) or that of recurrent pregnancy loss (RPL) group (median 92, range 20-205). The FXII activity of IVF-ET failure patients was positively correlated with age, but not associated with the number of IVF-ET failures, infertile duration, autoantibodies, or other coagulation parameters.
CONCLUSION:
Decreased FXII activity may causally relate to reproductive failure.
AuthorsHidehiko Matsubayashi, Toshitaka Sugi, Takahiro Suzuki, Noa Uchida, Haruyo Atsumi, Shun-ichiro Izumi, Mikio Mikami
JournalAmerican journal of reproductive immunology (New York, N.Y. : 1989) (Am J Reprod Immunol) Vol. 59 Issue 4 Pg. 316-22 (Apr 2008) ISSN: 1046-7408 [Print] Denmark
PMID18294355 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
Topics
  • Abortion, Habitual (blood, etiology)
  • Adult
  • Age Factors
  • Autoantibodies (blood)
  • Embryo Transfer
  • Factor XII Deficiency (complications)
  • Female
  • Fertilization in Vitro
  • Humans
  • Middle Aged
  • Partial Thromboplastin Time
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: